Evidence map›Paper›PMID 31261805›Full record

ArticleMedicina (Kaunas, Lithuania)2019

The Effect of Long-Term Second-Generation Antipsychotics Use on the Metabolic Syndrome Parameters in Jordanian Population.

Osama Abo Alrob, Sayer Alazzam, Karem Alzoubi, Mohammad B Nusair, Haneen Amawi, Reema Karasneh, Abeer Rababa'h, Mohammad Nammas

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Associations of theJournal of personalized medicine · 2021
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Osama Abo AlrobFaculty of Pharmacy, Yarmouk University, Irbid 22110, Jordan. osama.yousef@yu.edu.jo.
Sayer AlazzamFaculty of Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan. Salazzam@just.edu.jo.
Karem AlzoubiFaculty of Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan. khalzoubi@just.edu.jo.
Mohammad B NusairFaculty of Pharmacy, Yarmouk University, Irbid 22110, Jordan. nusair@yu.edu.jo.
Haneen AmawiFaculty of Pharmacy, Yarmouk University, Irbid 22110, Jordan. haneen.amawi@yu.edu.jo.
Reema KarasnehFaculty of Medicine, Yarmouk University, Irbid 22110, Jordan. reema.karasneh@yu.edu.jo.
Abeer Rababa'hFaculty of Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan. amrababah@just.edu.jo.
Mohammad NammasFaculty of Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan. mohamednamas2@gmail.com.
Jordan University of Science and Technology · JOYarmouk University · JO

Funding

Jordan University of Science and Technology 20180113
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAntidepressive Agents, Second-GenerationBlood GlucoseElectronic Health RecordsFemaleHumansJordanMaleMetabolic SyndromeMiddle AgedPopulation SurveillanceRetrospective StudiesRisk FactorsSchizophreniaTriglyceridesAntidepressive Agents, Second-GenerationBlood GlucoseTriglyceridesatypical antipsychoticsmetabolic syndromesecond-generation antipsychotics

Identifiers

PMID31261805
PMCPMC6681321
OpenAlexW2955644516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.